# LMLN

## Overview
LMLN, or leishmanolysin-like peptidase, is a gene that encodes a zinc metallopeptidase, which is a type of enzyme involved in the proteolytic degradation of proteins. This protein is categorized as a metalloprotease and plays a significant role in various biological processes, including the degradation of extracellular matrix components, cell migration, tissue remodeling, and signal transduction. LMLN is active in multiple cellular compartments, such as the extracellular space and cell membrane, and is involved in modulating immune responses and regulating cell proliferation and migration. The gene's activity is particularly relevant in the context of multiple myeloma, where it is negatively regulated by the microRNA miR-17-3p, influencing cell cycle progression and apoptosis (Xiang2021miR‐17‐3p; Cortez2006Functional).

## Function
LMLN, or leishmanolysin-like peptidase, is a gene that encodes a zinc metallopeptidase involved in various proteolytic processes. This protein is part of the metalloprotease family, which plays a crucial role in the degradation of extracellular matrix components, influencing cell migration, tissue remodeling, and signal transduction. LMLN is active in several cellular compartments, including the extracellular space and cell membrane, contributing to normal cellular and physiological functions (Xiang2021miR‐17‐3p).

In healthy human cells, LMLN is involved in modulating immune responses. It has been shown to suppress cell-mediated immune responses by down-regulating IL-12 production, which inhibits the classical activation of macrophages. This function suggests a role in dampening inflammatory responses, potentially as a mechanism to prevent excessive immune reactions (Cortez2006Functional).

LMLN's activity is also linked to cell proliferation and migration, as it is targeted by miR-17-3p in multiple myeloma cells, where its inhibition leads to increased cell proliferation. This indicates that LMLN may have a role in regulating cell cycle progression and maintaining cellular homeostasis (Xiang2021miR‐17‐3p).

## Clinical Significance
The LMLN gene, encoding leishmanolysin-like peptidase, has been implicated in the progression of multiple myeloma (MM), a hematological malignancy. In MM, the expression of miR-17-3p is elevated, which negatively regulates LMLN by binding to its 3'-UTR region. This interaction leads to the downregulation of LMLN, resulting in decreased expression of the cyclin-dependent kinase inhibitor p21. The reduction in p21 levels promotes the proliferation of MM cells, suggesting that LMLN acts as a tumor suppressor in this context (Xiang2021miR‐17‐3p).

The overexpression of miR-17-3p and subsequent inhibition of LMLN have been correlated with increased bone marrow plasma cell abundance and abnormal serum M protein levels in MM patients, indicating a role in disease progression. This miR-17-3p-LMLN-p21 axis highlights the potential of targeting these interactions for therapeutic intervention in MM (Xiang2021miR‐17‐3p).

While the Wang et al. study identified structural variations involving LMLN, such as a cryptic deletion and microduplication, it did not directly associate these alterations with specific diseases or conditions (Wang2022Detection).

## Interactions
LMLN, or leishmanolysin-like peptidase, is involved in various cellular processes, including cell migration, invasion, and mitotic progression. It is negatively regulated by miR-17-3p, a microRNA that directly binds to the 3' UTR region of LMLN, leading to reduced mRNA and protein levels. This interaction suggests that LMLN is a functional target of miR-17-3p, influencing cell proliferation and apoptosis in multiple myeloma cells (Xiang2021miR‐17‐3p). The inhibition of LMLN by miR-17-3p results in the downregulation of p21, a cyclin-dependent kinase inhibitor, which affects the cell cycle and promotes cell proliferation (Xiang2021miR‐17‐3p). 

While the specific protein interactions of LMLN are not detailed in the provided context, its role as a zinc-metallopeptidase suggests potential involvement in proteolytic processes and interactions with other proteins or nucleic acids. These interactions may be part of multiprotein complexes or involve transient interactions that influence cellular signaling and regulatory pathways. However, further research is needed to elucidate the precise molecular interactions and partners of LMLN in various cellular contexts.


## References


[1. (Wang2022Detection) Yanan Wang, Zhenhua Zhao, Xinyu Fu, Shufang Li, Qiuyan Zhang, and Xiangdong Kong. Detection of a cryptic 25 bp deletion and a 269 kb microduplication by nanopore sequencing in a seemingly balanced translocation involving the lmln and loc105378102 genes. Frontiers in Genetics, August 2022. URL: http://dx.doi.org/10.3389/fgene.2022.883398, doi:10.3389/fgene.2022.883398. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.883398)

[2. (Xiang2021miR‐17‐3p) Pu Xiang, Yiu To Yeung, Jiheng Wang, Qiong Wu, Ruijuan Du, Chuntian Huang, Xuechao Jia, Yunfeng Gao, Yafei Zhi, Fangqin Guo, Huifang Wei, Dandan Zhang, Yuzhang Liu, Lina Liu, Lijie Liang, Juan Wang, Yongping Song, Kangdong Liu, and Baijun Fang. <scp>mir</scp>‐17‐3p promotes the proliferation of multiple myeloma cells by downregulating <scp>p21</scp> expression through <scp>lmln</scp> inhibition. International Journal of Cancer, 148(12):3071–3085, March 2021. URL: http://dx.doi.org/10.1002/ijc.33528, doi:10.1002/ijc.33528. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ijc.33528)

[3. (Cortez2006Functional) Karoll J. Cortez, Caron A. Lyman, Shyam Kottilil, Hee Sup Kim, Emmanuel Roilides, Jun Yang, Brandie Fullmer, Richard Lempicki, and Thomas J. Walsh. Functional genomics of innate host defense molecules in normal human monocytes in response toaspergillus fumigatus. Infection and Immunity, 74(4):2353–2365, April 2006. URL: http://dx.doi.org/10.1128/iai.74.4.2353-2365.2006, doi:10.1128/iai.74.4.2353-2365.2006. This article has 74 citations and is from a peer-reviewed journal.](https://doi.org/10.1128/iai.74.4.2353-2365.2006)